Altium Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Altium Capital Management's CDNA Position: Q4 2021 in Review
Altium Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 90,000 shares — an estimated $5.7M sold.
Altium Capital Management first reported a position in CDNA in Q1 2021 and held it in 3 quarters. The position peaked at $5.8M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Altium Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
- Altium Capital Management sold 90,000 CareDx shares in Q4 2021, an estimated $5.7M.
- Altium Capital Management first reported a position in CareDx in Q1 2021 and held it in 3 quarters.
- Altium Capital Management's CareDx position peaked at $5.8M in Q2 2021.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.